Banque Transatlantique Sa Ocugen, Inc. Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Ocugen, Inc. stock. As of the latest transaction made, Banque Transatlantique Sa holds 1,200 shares of OCGN stock, worth $1,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200Holding current value
$1,116% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
118Shares Held
75.1MCall Options Held
200KPut Options Held
151K-
Black Rock Inc. New York, NY17.9MShares$16.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.7MShares$15.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$6.41 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$5.52 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$4.06 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $201M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...